Urologix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ULGX research report →
Price Chart
About the company
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia (BPH).
- CEO
- Bryon Merade
- IPO
- 1996
- Employees
- 61
- HQ
- Minneapolis, MN, US
Get TickerSpark's AI analysis on ULGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.18K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.73
- Div Yield
- 0.00%
- Gross Margin
- 42.80%
- Op Margin
- -48.68%
- Net Margin
- -53.45%
- ROE
- 232.06%
- ROIC
- -235.46%
Latest fiscal year · YoY change
- Revenue
- $14.23M-14.2%
- Gross Profit
- $6.09M-25.5%
- Op Income
- $-6,930,000
- Net Income
- $-7,608,000-77.3%
- EPS
- $-0.36-71.4%
- OCF Growth
- +21.9%
- FCF Growth
- +22.9%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.77
- RSI (14)
- 48
- Avg Volume
- 1.34K
No earnings-call transcripts are available for ULGX yet.
- Free Float
- 94.5%
- Shares Outstanding
- 21.82M
- Float Shares
- 20.61M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 19, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 20, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 6, 14 | EMERY SIDNEY W JR | other | 45,455 |
| Nov 7, 13 | Spangler Patrick D | other | 50,000 |
| Nov 7, 13 | Barys Christopher R | other | 50,000 |
| Nov 7, 13 | EMERY SIDNEY W JR | other | 50,000 |
| Nov 7, 13 | DANN MITCHELL | other | 50,000 |
| Aug 26, 13 | Fluet Gregory | buy | 17,500 |
| Aug 14, 13 | Smrdel Brian J | other | 17,500 |
| Aug 14, 13 | Smrdel Brian J | other | 15,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ULGX coverage
Recent articles, reports, and earnings notes.
No research on ULGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ULGX report →